Fortress Biotech (FBIO) Tops Q2 EPS by 16c

Fortress Biotech (NASDAQ: FBIO) reported Q2 EPS of ($0.07), $0.16 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $17.39 million versus the consensus estimate of $15.46 million.

For earnings history and earnings-related data on Fortress Biotech (FBIO) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• VIST Financial Corp. (VIST) Misses Q2 EPS by 76c
• DB cautious on cruise stocks as fundamentals “not as clear as bulls believe”